Healthcare -
Biotechnology - NASDAQ - US
$ 0.6601
-5.47 %
$ 83.3 M
Market Cap
-0.63
P/E
KPTI - OTHER LONG-TERM ASSETS
Other Long-term Assets KPTI - Karyopharm Therapeutics Inc.
1.64 M
LAST VALUE
-80.92%
2 YEAR CAGR
17.96%
5 YEAR CAGR
49.16%
10 YEAR CAGR